Skip to main content

High-Dose Cytosine Arabinoside in the Treatment of Acute Lymphoblastic Leukaemia

  • Conference paper
  • 68 Accesses

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 36))

Abstract

“High-dose” cytosine arabinoside (HD-ara-C) was introduced into the management of acute lymphoblastic leukaemia (ALL) in adults at St. Bartholomew’s Hospital (SBH), London, Ospedali Riuniti, Bergamo and Ospedale San Bortolo, Vicenza in 1981. Prior to this time, a strategy of remission induction and consolidation with adriamycin, vincristine prednisolone and L-asparaginase (OPAL) [1,2], with subsequent dose escalation and addition of cyclophosphamide (HEAV’D) [2,3], followed by cranial irradiation and maintenance chemotherapy, left much room for improvement. Analysis of the prognostic significance of pretreatment variables made it possible to assign patients to either “low-risk” (cALLa positive, blast count < 10 × 109/I) or “high-risk” (the rest) categories [2].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lister T A, Whitehouse JMA, Beard MEJ et al. (1978) Combination chemotherapy for acute lymphoblastic leukaemia in adults. Br Med J 1: 199

    Article  PubMed  CAS  Google Scholar 

  2. Barnett MJ, Greaves MF, Amess JAL et al. (1986) Treatment of acute lymphoblastic leukaemia in adults. Br J Haematol 64: 455

    Article  PubMed  CAS  Google Scholar 

  3. Bassan R, Battista R, Rohatiner AZS et al. (1992) Treatment of adult acute lymphoblastic (ALL) over a 16 year period. Leukaemia 6(2): 186

    Google Scholar 

  4. Howard JP, Albo V, Newton WA (1968) Cytosine arabinoside. Results of a cooperative study in acute childhood leukaemia. Cancer 21: 341–345

    Article  PubMed  CAS  Google Scholar 

  5. Wang JJ, Selawry OS, Vietti TU, Bodey GP (1970) Prolonged infusion of arabinosyl cytosine in childhood leukaemia. Cancer 25: 1–6

    Article  PubMed  CAS  Google Scholar 

  6. Rudnick SA, Cadman EC, Capizzi RL et al. (1979) High dose Cytosine arabinoside (HDARA-C) in refractory acute leukaemia. Cancer 44: 1189–1193

    Article  PubMed  CAS  Google Scholar 

  7. Slevin ML, Piall EM, Aherne GW et al. (1983) Effect of dose and schedule on pharmacokinetics of high-dose Cytosine arabinoside in plasma and cerebrospinal fluid. J Clin Oncol 1: 546–551

    PubMed  CAS  Google Scholar 

  8. Rohatiner AZS, Slevin ML, Dhaliwal HS, Malpas JS, Lister TA (1984) High dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin’s lymphoma. Cancer Chemo Pharmacol 12: 90

    CAS  Google Scholar 

  9. Barnett M, Rohatiner AZS, Ganesan TS et al. (1987) A phase II study of high-dose Cytosine arabinoside in the treatment of acute leukaemia in adults. Cancer Chemo Pharmacol 19: 169–171

    CAS  Google Scholar 

  10. Rohatiner AZS, Bassan R, Battista R et al. (1990) High dose Cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia. Br J Cancer 62: 454–458

    Article  PubMed  CAS  Google Scholar 

  11. Ritz J et al. (1982) Autologous bone marrow transplantation in cALLa positive acute lymphoblastic leukaemia after in vitro treatment with J5 monoclonal antibody and complement. Lancet 2: 60

    Article  PubMed  CAS  Google Scholar 

  12. Sallan S et al. (1991) Blood

    Google Scholar 

  13. Thorpe PE et al. (1982) Selective killing of malignant cells in a leukaemic rat bone marrow ising an antibody-Ricin conjugate. Nature 297: 594

    Article  PubMed  CAS  Google Scholar 

  14. Hoelzer D, Thiel E, Loffer H et al. (1984) Intensified therapy in acute lymphoblastic and acute undifferentiated leukaemia in adults. Blood 64: 38

    PubMed  CAS  Google Scholar 

  15. Clarkson B, Gaynor J, Little C et al. (1990) Clinical trials in adults with acute lymphoblastic leukaemia at Memorial Sloan-Kettering Cancer Centre. Acute Lymphoblastic Leukaemia, Eds Gale & Hoelzer, 231–252

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Rohatiner, A.Z.S. et al. (1994). High-Dose Cytosine Arabinoside in the Treatment of Acute Lymphoblastic Leukaemia. In: Büchner, T., Hiddemann, W., Wörmann, B., Schellong, G., Ritter, J. (eds) Acute Leukemias IV. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78350-0_78

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78350-0_78

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-78352-4

  • Online ISBN: 978-3-642-78350-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics